Loading
Cambridge medical oncologist and Interim Deputy Director of the CRUK Cambridge Institute, a leader in ovarian cancer genomics and ctDNA monitoring.
James Brenton is Interim Deputy Director and a Senior Group Leader at the Cancer Research UK Cambridge Institute, and a consultant medical oncologist at Cambridge University Hospitals. His research focuses on the genomics and evolution of high-grade serous ovarian cancer and on circulating tumour DNA as a tool for treatment monitoring. He leads the ovarian cancer programme within the CRUK Cambridge Centre.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Cancer Research UK Cambridge Centre / CRUK Cambridge Institute and the tags leadership, clinician-scientist.
Shares PLOS Medicine and the tag leadership.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Ovarian cancer and the tags leadership, clinician-scientist.